Five Florida Ophthalmology Practices Agree to Nearly $6 Million Settlement Over Medicare and Medicaid Billing Scheme

Federal authorities have reached civil settlements totaling nearly $6 million with five Florida-based ophthalmology practices accused of participating in a years-long scheme that improperly billed Medicare and Medicaid for medically unnecessary cranial ultrasound procedures. The case highlights how financial incentives embedded in referral and testing arrangements can distort medical decision-making and expose federal healthcare programs to sustained abuse.

The practices involved — Clay Eye Holdings LLC, Retina Macula Specialist of Miami LLC, Florida Eye Institute P.A., Miami Eye LLC, and Kendall Eye Institute Inc. — agreed to resolve allegations that they submitted or caused the submission of false claims for transcranial Doppler ultrasounds (TCDs) through an unlawful kickback arrangement with a third-party testing company. All five entities have also agreed to cooperate with ongoing federal investigations into other participants connected to the alleged scheme.

---

A Testing Model Built on Volume, Not Medical Need

According to federal allegations, the practices routinely ordered TCDs for thousands of patients and billed Medicare and Medicaid hundreds of dollars per test. Prior to patients receiving any test results, both the practices and the third-party testing company allegedly designated patients as having serious neurological diagnoses that could justify reimbursement for the procedure.

Investigators determined that in the overwhelming majority of cases, those diagnoses were not supported by the patients’ medical histories, were not reflected in the test results themselves, and were not clinically justified. Despite this, claims were submitted to federal healthcare programs as if the procedures were medically necessary.

The scheme was further reinforced through financial incentives. The ophthalmology practices allegedly paid the third-party testing company based on the volume or value of TCDs ordered and referred patients to a radiology group preferred by the testing company for the professional interpretation component of the exams. Federal authorities allege this structure violated both the Anti-Kickback Statute and the Stark Law, which are designed to prevent financial relationships from influencing medical referrals.

---

Multi-Year Exposure Across Federal Healthcare Programs

The United States alleges that false claims were submitted between January 1, 2018, and June 1, 2022. During that period, the practices are accused of generating claims for TCDs that were medically unnecessary, premised on false diagnoses, and tainted by unlawful referral arrangements.

The financial resolution reflects the scope of exposure attributed to each practice:

• Clay Eye Holdings LLC: $2,140,000
• Retina Macula Specialist of Miami LLC: $1,750,000
• Florida Eye Institute P.A.: $1,250,000
• Miami Eye LLC: $525,000
• Kendall Eye Institute Inc.: $310,000

Of the total settlement amount, $333,500 will be allocated to the State of Florida for its share of Medicaid losses, reflecting the joint federal-state funding structure of the program.

---

Whistleblower Role and Enforcement Mechanism

The case originated under the whistleblower, or qui tam, provisions of the False Claims Act, which allow private individuals to file lawsuits on behalf of the government when they believe fraud has occurred. In this matter, the whistleblower will receive $1,135,250 as a share of the government’s recovery.

Federal officials emphasized that whistleblower actions remain one of the most effective mechanisms for uncovering complex healthcare fraud schemes that are difficult to detect through routine audits alone, particularly when improper practices are normalized across multiple providers.

---

Coordinated Federal Oversight

The investigation and settlement involved coordination among federal civil prosecutors, healthcare fraud specialists, and law enforcement agencies tasked with protecting the integrity of Medicare and Medicaid. Authorities have indicated that similar conduct by other providers has already resulted in prior settlements and that investigations into related actors remain ongoing.

Federal officials reiterated that civil settlements resolve allegations only and do not constitute a determination of liability. However, the enforcement action reflects a broader federal emphasis on identifying billing patterns that prioritize revenue generation over patient care and compliance.

---

TRJ Verdict

Healthcare fraud does not always take the form of phantom billing or fabricated patients. Increasingly, it operates through systems that appear clinically legitimate on the surface but are financially engineered beneath it. When diagnostic testing is driven by referral incentives and volume-based payments, medical judgment becomes secondary to revenue flow. Settlements like this signal enforcement, but they also expose a structural problem: compliance mechanisms that react after years of losses rather than preventing exploitation at the point of care. Until financial incentives are disentangled from clinical decision-making, federal healthcare programs will remain vulnerable to schemes that monetize trust under the guise of medicine.

---

---

---

---

---

---

---

---

🔥 NOW AVAILABLE! 🔥

‎👉 Eclipsera – Apple Music

---

---

---

---